While passenger mutations are generally not considered ideal biomarkers for cancer diagnosis or prognosis, they can provide valuable information about the tumor's genetic diversity and evolution. In some cases, the presence of specific passenger mutations may correlate with particular cancer subtypes or treatment responses. However, more research is needed to fully understand the potential of passenger mutations as biomarkers.
